RBC Europe’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-600
Closed -$7.9K 1250
2021
Q3
$7.9K Hold
600
﹤0.01% 980
2021
Q2
$24K Buy
+600
New +$23.7K ﹤0.01% 770

Other funds holding ZY

RBC Europe's ZY Position: Q4 2021 in Review

RBC Europe sold out of Zymergen Inc. Common Stock (ZY) in Q4 2021, closing a stake of 600 shares — an estimated $7.9K sold.

RBC Europe first reported a position in ZY in Q2 2021 and held it in 2 quarters. The position peaked at $24K in Q2 2021. 91 funds tracked by Wall St. Rank hold ZY as of Q4 2021.

  • RBC Europe reported no remaining Zymergen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 600 Zymergen Inc. Common Stock shares in Q4 2021, an estimated $7.9K.
  • RBC Europe first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • RBC Europe's Zymergen Inc. Common Stock position peaked at $24K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.